Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023	Jun. 30, 2022
Current assets
Cash and cash equivalents	$ 242	$ 183
Receivables, net	678	681
Inventories, net	735	755
Prepaid expenses and other current assets	90	106
Total current assets	1,745	1,725
Property, plant and equipment, net of accumulated depreciation and amortization of $2,672 and $2,530, respectively	1,315	1,334
Operating lease right-of-use assets	359	342
Goodwill	1,250	1,558
Trademarks, net	546	687
Other intangible assets, net	176	197
Other assets	427	315
Total assets	5,818	6,158
Current liabilities
Notes and loans payable	138	237
Current operating lease liabilities	88	78
Accounts payable and accrued liabilities	1,722	1,469
Income taxes payable	48	0
Total current liabilities	1,996	1,784
Long-term debt	2,476	2,474
Long-term operating lease liabilities	323	314
Other liabilities	824	791
Deferred income taxes	27	66
Total liabilities	5,646	5,429
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March 31, 2023 and June 30, 2022; and 123,611,466 and 123,152,132 shares outstanding as of March 31, 2023 and June 30, 2022, respectively	131	131
Additional paid-in capital	1,232	1,202
Retained earnings	415	1,048
Treasury stock, at cost: 7,129,995 and 7,589,329 shares as of March 31, 2023 and June 30, 2022, respectively	(1,277)	(1,346)
Accumulated other comprehensive net (loss) income	(498)	(479)
Total Clorox stockholders’ equity	3	556
Noncontrolling interests	169	173
Total stockholders’ equity	172	729
Total liabilities and stockholders’ equity	$ 5,818	$ 6,158